Gilead signed a massive deal with Galapagos. After a restructuring, the pharma is still hunting for the potential it saw at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Fintel reports that on January 10, 2025, Morgan Stanley upgraded their outlook for Gilead Sciences (SNSE:GILD) from Equal-Weight to Overweight. There are 2,888 funds or institutions reporting ...

The alarm was raised at around 6.30pm and four units of Cork City Fire Brigade rushed to the scene at the Sarsfield Court Industrial Estate in Glanmire An investigation is underway after several ...

The most recent trading session ended with Gilead Sciences (GILD) standing at $91.41, reflecting a -0.51% shift from the previouse trading day's closing. The stock's performance was behind the S&P ...

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other dividend stocks. Macroeconomic factors have weighed on US stocks in the final ...

ALL YEAR: Island City - Cork’s Urban Sculpture Trail, Cork City If you are looking for something unique to explore in Cork, don’t miss Island City: Cork’s Urban Sculpture Trail. This ...

It's the only budget supermarket right in the heart of Cork City - a place for those without a car or who live in and around the city centre can go to do their Big Shop, snag a cheap lunch or just ...

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively ...

HPV-16 E7 is under clinical development by Gilead Sciences and currently in Phase II for Human Papillomavirus (HPV) Associated Cancer. According to GlobalData, Phase II drugs for Human Papillomavirus ...